New York Oncology Hematology - Albany Cancer Center /ID# 223778 — Albany, New York

New York Oncology Hematology - Albany Cancer Center /ID# 223778 is a clinical research site located in Albany, New York, United States 12206-5013.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology - Albany Cancer Center /ID# 223778 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelodysplastic Syndrome (MDS).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology - Albany Cancer Center /ID# 223778?

New York Oncology Hematology - Albany Cancer Center /ID# 223778 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology - Albany Cancer Center /ID# 223778 conducted?

New York Oncology Hematology - Albany Cancer Center /ID# 223778 has 1 clinical trials on record, with 1 currently active. Their work covers Myelodysplastic Syndrome (MDS).

Is New York Oncology Hematology - Albany Cancer Center /ID# 223778 accredited by Crixeo Health?

New York Oncology Hematology - Albany Cancer Center /ID# 223778 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology - Albany Cancer Center /ID# 223778?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.